2016 IDEOM Winter Newsletter
On Friday, January 29, 2016 – IDEOM, in collaboration with the NPF, held a roundtable meeting to bring to the table and better understand how payers define value/quality and how outcome measures are used by payer decision-making. At the table were IDEOM Board members, NPF leaders, patients and payers from BlueCross BlueShield, Medicaid and other healthcare consultants in high level positions.
This past meeting with the payers was groundbreaking for IDEOM and all its stakeholders, and we are happy to announce that we are actively growing our stakeholder payer contact list so we can thoroughly carry out our mission in measuring outcomes. A full report to all IDEOM stakeholders will be give a the upcoming IDEOM 2016 meeting in Washington, D.C., as well as a keynote address from Kendall Marcus, MD, Director, Division of Dermatology and Dental Products (DDDP).
Thanks to Our Corporate Sponsors & Donors
• To establish patient-centered measurements to enhance research and treatment for those with dermatologic disease
• Perspectives of patients, health economists, payers, physicians and regulatory agencies are included from the onset
• IDEOM’s goal is to establish validated and standardized outcome measures that satisfy the needs of all stakeholders and can be applied to clinical research and clinical practice